Where Discovery Begins
Anti-H_Tigit hIgG1 Antibody(Vibostolimab)
Research Grade
Cat. No.
GM-24029AB
Size
10 μg
100 μg
1 mg
Quote
Data display
Description
Related products
Data display
Flow cytometry
H_TIGIT CHO-K1 Cell Line(Catalog # GM-C18929) was stained with Anti-H_Tigit hIgG1 Antibody(Vibostolimab) or isotype control antibody.
Cynomolgus_TIGIT CHO-K1 Cell Line (Catalog # GM-C21597) was stained with Anti-H_Tigit hIgG1 Antibody(Vibostolimab) or isotype control antibody.
Activation assay
Serial dilutions of Anti-Tigit hIgG1 Antibody (1:4 serial dilutions, from 30 μg/mL to 457 pg/mL) (Catalog # GM-24209AB) were added into H_TIGIT CD226 Reporter Jurkat Cell Line (Catalog # GM-C20072). Then H_TIGIT CD226 Reporter Jurkat Cell Line was binded with H_PVR(CD155) Raji Cell Line (Catalog # GM-C09243).EC50 for this effect was 0.8371 μg/mL.
Bioactivity-ELISA
Human TIGIT Protein; His Tag (Catalog # GM-87661RP) was immobilized at 1 μg/ml (100 μL/well). Increasing concentrations of Anti-H_Tigit hIgG1 Antibody(Vibostolimab) (Catalog # GM-24029AB) were added.
Description
Species Reactivity Human; Cynomolgus
Clone Vibostolimab
Source/Isotype Monoclonal human IgG1, κ
Application Flow cytometry; Activation assay; Bioactivity-ELISA
Other Names VSIG9; VSTM3; WUCAM
Gene ID 201633
Background T cell immunoglobulin and ITIM domain (TIGIT) is an inhibitory receptor expressed on lymphocytes that was recently propelled under the spotlight as a major emerging target in cancer immunotherapy. TIGIT interacts with CD155 expressed on antigen‐presenting cells or tumour cells to down‐regulate T cell and natural killer (NK) cell functions. TIGIT marks exhausted T cells in the tumor microenvironment and during human immunodeficiency virus (HIV) infection. Research has shown TIGIT interacts with several receptors expressed on antigen presenting cells, such as dendritic cells and macrophages, as well as tumor cells and cells of the microenvironment.
Storage Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.
Formulation Phosphate-buffered solution, pH 7.2.
Endotoxin < 1 EU/mg, determined by LAL gel clotting assay
Species Reactivity Human; Cynomolgus
Clone Vibostolimab
Source/Isotype Monoclonal human IgG1, κ
Application Flow cytometry; Activation assay; Bioactivity-ELISA
Other Names VSIG9; VSTM3; WUCAM
Gene ID 201633
Background T cell immunoglobulin and ITIM domain (TIGIT) is an inhibitory receptor expressed on lymphocytes that was recently propelled under the spotlight as a major emerging target in cancer immunotherapy. TIGIT interacts with CD155 expressed on antigen‐presenting cells or tumour cells to down‐regulate T cell and natural killer (NK) cell functions. TIGIT marks exhausted T cells in the tumor microenvironment and during human immunodeficiency virus (HIV) infection. Research has shown TIGIT interacts with several receptors expressed on antigen presenting cells, such as dendritic cells and macrophages, as well as tumor cells and cells of the microenvironment.
Storage Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.
Formulation Phosphate-buffered solution, pH 7.2.
Endotoxin < 1 EU/mg, determined by LAL gel clotting assay
Related products
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
Anti-H_Tigit hIgG1 Antibody(Vibostolimab)
Research Grade
Anti-H_Tigit hIgG1 Antibody(Vibostolimab)
Research Grade
Cat. No.
GM-24029AB
Size
10 μg
100 μg
1 mg
Quote
Data display
Description
Related products
Data display
Flow cytometry
H_TIGIT CHO-K1 Cell Line(Catalog # GM-C18929) was stained with Anti-H_Tigit hIgG1 Antibody(Vibostolimab) or isotype control antibody.
Cynomolgus_TIGIT CHO-K1 Cell Line (Catalog # GM-C21597) was stained with Anti-H_Tigit hIgG1 Antibody(Vibostolimab) or isotype control antibody.
Activation assay
Serial dilutions of Anti-Tigit hIgG1 Antibody (1:4 serial dilutions, from 30 μg/mL to 457 pg/mL) (Catalog # GM-24209AB) were added into H_TIGIT CD226 Reporter Jurkat Cell Line (Catalog # GM-C20072). Then H_TIGIT CD226 Reporter Jurkat Cell Line was binded with H_PVR(CD155) Raji Cell Line (Catalog # GM-C09243).EC50 for this effect was 0.8371 μg/mL.
Bioactivity-ELISA
Human TIGIT Protein; His Tag (Catalog # GM-87661RP) was immobilized at 1 μg/ml (100 μL/well). Increasing concentrations of Anti-H_Tigit hIgG1 Antibody(Vibostolimab) (Catalog # GM-24029AB) were added.
Description
Species Reactivity Human; Cynomolgus
Clone Vibostolimab
Source/Isotype Monoclonal human IgG1, κ
Application Flow cytometry; Activation assay; Bioactivity-ELISA
Other Names VSIG9; VSTM3; WUCAM
Gene ID 201633
Background T cell immunoglobulin and ITIM domain (TIGIT) is an inhibitory receptor expressed on lymphocytes that was recently propelled under the spotlight as a major emerging target in cancer immunotherapy. TIGIT interacts with CD155 expressed on antigen‐presenting cells or tumour cells to down‐regulate T cell and natural killer (NK) cell functions. TIGIT marks exhausted T cells in the tumor microenvironment and during human immunodeficiency virus (HIV) infection. Research has shown TIGIT interacts with several receptors expressed on antigen presenting cells, such as dendritic cells and macrophages, as well as tumor cells and cells of the microenvironment.
Storage Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.
Formulation Phosphate-buffered solution, pH 7.2.
Endotoxin < 1 EU/mg, determined by LAL gel clotting assay
Species Reactivity Human; Cynomolgus
Clone Vibostolimab
Source/Isotype Monoclonal human IgG1, κ
Application Flow cytometry; Activation assay; Bioactivity-ELISA
Other Names VSIG9; VSTM3; WUCAM
Gene ID 201633
Background T cell immunoglobulin and ITIM domain (TIGIT) is an inhibitory receptor expressed on lymphocytes that was recently propelled under the spotlight as a major emerging target in cancer immunotherapy. TIGIT interacts with CD155 expressed on antigen‐presenting cells or tumour cells to down‐regulate T cell and natural killer (NK) cell functions. TIGIT marks exhausted T cells in the tumor microenvironment and during human immunodeficiency virus (HIV) infection. Research has shown TIGIT interacts with several receptors expressed on antigen presenting cells, such as dendritic cells and macrophages, as well as tumor cells and cells of the microenvironment.
Storage Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.
Formulation Phosphate-buffered solution, pH 7.2.
Endotoxin < 1 EU/mg, determined by LAL gel clotting assay
Related products
Contact
Us
Message Inquiry
reset
submit
Message
Message Inquiry
reset
submit